Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation.

Growth differentiation factor 11 (GDF11) and myostatin (or GDF8) are closely related members of the transforming growth factor β superfamily and are often perceived to serve similar or overlapping roles. Yet, despite commonalities in protein sequence, receptor utilization and signaling, accumulating evidence suggests that these 2 ligands can have distinct functions in many situations. GDF11 is essential for mammalian development and has been suggested to regulate aging of multiple tissues, whereas myostatin is a well-described negative regulator of postnatal skeletal and cardiac muscle mass and modulates metabolic processes. In this review, we discuss the biochemical regulation of GDF11 and myostatin and their functions in the heart, skeletal muscle, and brain. We also highlight recent clinical findings with respect to a potential role for GDF11 and/or myostatin in humans with heart disease. Finally, we address key outstanding questions related to GDF11 and myostatin dynamics and signaling during development, growth, and aging. # Response to Walker et al {#article-title-171}

[1]  M. Franti,et al.  Crystal structure of human GDF11. , 2016, Acta crystallographica. Section F, Structural biology communications.

[2]  T. Mueller,et al.  Structural insights into BMP receptors: Specificity, activation and inhibition. , 2016, Cytokine & growth factor reviews.

[3]  P. López-Jaramillo The Role of Adiponectin in Cardiometabolic Diseases: Effects of Nutritional Interventions. , 2016, The Journal of nutrition.

[4]  Richard T. Lee,et al.  Circulating Growth Differentiation Factor 11/8 Levels Decline With Age. , 2016, Circulation research.

[5]  E. McNally Questions and Answers About Myostatin, GDF11, and the Aging Heart. , 2016, Circulation research.

[6]  David G. Sterling,et al.  Association of growth differentiation factor 11/8, putative anti-ageing factor, with cardiovascular outcomes and overall mortality in humans: analysis of the Heart and Soul and HUNT3 cohorts. , 2015, European heart journal.

[7]  M. Jensen,et al.  Targeting senescent cells enhances adipogenesis and metabolic function in old age , 2015, eLife.

[8]  S. Houser,et al.  GDF11 does not rescue aging-related pathological hypertrophy. , 2015, Circulation research.

[9]  S. Carmichael,et al.  GDF10 Is a Signal for Axonal Sprouting and Functional Recovery after Stroke , 2015, Nature Neuroscience.

[10]  B. Spiegelman,et al.  Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry. , 2015, Cell metabolism.

[11]  W. Mitch,et al.  Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues , 2015, International Journal of Obesity.

[12]  B. D. Rodgers,et al.  Reduced Circulating GDF11 Is Unlikely Responsible for Age-Dependent Changes in Mouse Heart, Muscle, and Brain. , 2015, Endocrinology.

[13]  D. Nemet,et al.  Frequency of the MSTN Lys(K)-153Arg(R) polymorphism among track & field athletes and swimmers. , 2015, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[14]  BerdeliAfig,et al.  Myostatin Gene Polymorphism in an Elderly Sarcopenic Turkish Population , 2015 .

[15]  H. R. Bergen,et al.  Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay , 2015, Skeletal Muscle.

[16]  I. Clay,et al.  GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration. , 2015, Cell metabolism.

[17]  J. Massagué,et al.  Structural determinants of Smad function in TGF-β signaling. , 2015, Trends in biochemical sciences.

[18]  Eric P. Hoffman,et al.  Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy , 2015, Proceedings of the National Academy of Sciences.

[19]  Konstantin I Bakhurin,et al.  Haploinsufficiency of myostatin protects against aging-related declines in muscle function and enhances the longevity of mice , 2015, Aging cell.

[20]  David G. Sterling,et al.  LOW LEVELS OF GROWTH DIFFERENTIATION FACTOR 11 AND HIGH LEVELS OF ITS INHIBITOR FOLLISTATIN-LIKE 3 ARE ASSOCIATED WITH ADVERSE CARDIOVASCULAR OUTCOMES IN HUMANS , 2015 .

[21]  T. Borchardt,et al.  Myostatin induces interstitial fibrosis in the heart via TAK1 and p38 , 2015, Cell and Tissue Research.

[22]  Yun‐Sil Lee,et al.  Alternative Binding Modes Identified for Growth and Differentiation Factor-associated Serum Protein (GASP) Family Antagonism of Myostatin* , 2015, The Journal of Biological Chemistry.

[23]  H. Sweeney,et al.  Cardiac myostatin upregulation occurs immediately after myocardial ischemia and is involved in skeletal muscle activation of atrophy. , 2015, Biochemical and biophysical research communications.

[24]  L. Buday,et al.  K153R polymorphism in myostatin gene increases the rate of promyostatin activation by furin , 2015, FEBS letters.

[25]  Y. Sunada,et al.  Identification of the minimum peptide from mouse myostatin prodomain for human myostatin inhibition. , 2015, Journal of medicinal chemistry.

[26]  T. Borchardt,et al.  Myostatin Regulates Energy Homeostasis in the Heart and Prevents Heart Failure ” , 2015 .

[27]  N. Perrimon,et al.  Intertissue control of the nucleolus via a myokine-dependent longevity pathway. , 2014, Cell reports.

[28]  T. Wyss-Coray,et al.  ALK5-dependent TGF-β signaling is a major determinant of late stage adult neurogenesis , 2014, Nature Neuroscience.

[29]  Richard T. Lee,et al.  Restoring Systemic GDF11 Levels Reverses Age-Related Dysfunction in Mouse Skeletal Muscle , 2014, Science.

[30]  Richard T. Lee,et al.  Vascular and Neurogenic Rejuvenation of the Aging Mouse Brain by Young Systemic Factors , 2014, Science.

[31]  Danielle A. Simmons,et al.  Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice , 2014, Nature Medicine.

[32]  R. Paulson Targeting a new regulator of erythropoiesis to alleviate anemia , 2014, Nature Medicine.

[33]  A. Grinberg,et al.  Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis , 2014, Nature Medicine.

[34]  A. Fricot,et al.  An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia , 2014, Nature Medicine.

[35]  L. Wen,et al.  The A55T and K153R polymorphisms of MSTN gene are associated with the strength training-induced muscle hypertrophy among Han Chinese men , 2014, Journal of sports sciences.

[36]  N. LeBrasseur,et al.  Myostatin and Sarcopenia: Opportunities and Challenges - A Mini-Review , 2014, Gerontology.

[37]  S. Brachat,et al.  An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy , 2013, Molecular and Cellular Biology.

[38]  H. Heuft,et al.  Highly Specific Detection of Myostatin Prodomain by an Immunoradiometric Sandwich Assay in Serum of Healthy Individuals and Patients , 2013, PloS one.

[39]  T. Rando,et al.  Numb-deficient satellite cells have regeneration and proliferation defects , 2013, Proceedings of the National Academy of Sciences.

[40]  Yun‐Sil Lee,et al.  Regulation of GDF-11 and myostatin activity by GASP-1 and GASP-2 , 2013, Proceedings of the National Academy of Sciences.

[41]  L. Patthy,et al.  Latent myostatin has significant activity and this activity is controlled more efficiently by WFIKKN1 than by WFIKKN2 , 2013, The FEBS journal.

[42]  Richard T. Lee,et al.  Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy , 2013, Cell.

[43]  S. Kuang,et al.  Myostatin knockout drives browning of white adipose tissue through activating the AMPK‐PGC1α‐Fndc5 pathway in muscle , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  A. Datta-Mannan,et al.  An Engineered Human Follistatin Variant: Insights into the Pharmacokinetic and Pharmocodynamic Relationships of a Novel Molecule with Broad Therapeutic Potential , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[45]  A. Lucia,et al.  Genes, physical fitness and ageing , 2013, Ageing Research Reviews.

[46]  G. Ricevuti,et al.  Association of the K153R polymorphism in the myostatin gene and extreme longevity , 2013, AGE.

[47]  P. Carmeliet,et al.  Cripto regulates skeletal muscle regeneration and modulates satellite cell determination by antagonizing myostatin , 2012, Proceedings of the National Academy of Sciences.

[48]  S. Falconer,et al.  Growth and differentiation factor-11 is developmentally regulated in skeletal muscle and inhibits myoblast differentiation , 2012 .

[49]  B. D. Rodgers,et al.  Myostatin inhibits myosatellite cell proliferation and consequently activates differentiation: evidence for endocrine-regulated transcript processing. , 2012, The Journal of endocrinology.

[50]  J. Massagué TGFβ signalling in context , 2012, Nature Reviews Molecular Cell Biology.

[51]  N. Rosenthal,et al.  Follistatin-Like 3 Mediates Paracrine Fibroblast Activation by Cardiomyocytes , 2012, Journal of Cardiovascular Translational Research.

[52]  S. Jain,et al.  Association of the Myostatin Gene with Obesity, Abdominal Obesity and Low Lean Body Mass and in Non-Diabetic Asian Indians in North India , 2012, PloS one.

[53]  M. Matzuk,et al.  Role of satellite cells versus myofibers in muscle hypertrophy induced by inhibition of the myostatin/activin signaling pathway , 2012, Proceedings of the National Academy of Sciences.

[54]  James M. Allen,et al.  Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin , 2012, The Journal of cell biology.

[55]  F. Muntoni,et al.  Donor Satellite Cell Engraftment is Significantly Augmented When the Host Niche is Preserved and Endogenous Satellite Cells are Incapacitated , 2012, Stem cells.

[56]  I. Komuro,et al.  Complement C1q Activates Canonical Wnt Signaling and Promotes Aging-Related Phenotypes , 2012, Cell.

[57]  H. Keutmann,et al.  Characterization of follistatin-type domains and their contribution to myostatin and activin A antagonism. , 2012, Molecular endocrinology.

[58]  P. Hoen,et al.  Cell‐type specific regulation of myostatin signaling , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[59]  L. Kunkel,et al.  β4 Integrin Marks Interstitial Myogenic Progenitor Cells in Adult Murine Skeletal Muscle , 2012, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[60]  Chandramohan Kattamuri,et al.  Structure of Myostatin·Follistatin-like 3 , 2011, The Journal of Biological Chemistry.

[61]  N. Frangogiannis,et al.  Transforming growth factor (TGF)-β signaling in cardiac remodeling. , 2011, Journal of molecular and cellular cardiology.

[62]  C. Harrison,et al.  Prodomains regulate the synthesis, extracellular localisation and activity of TGF-β superfamily ligands , 2011, Growth factors.

[63]  H. Sweeney,et al.  Myostatin Is Elevated in Congenital Heart Disease and After Mechanical Unloading , 2011, PloS one.

[64]  T. Walz,et al.  Latent TGF-β structure and activation , 2011, Nature.

[65]  D. Kass,et al.  Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload. , 2011, The Journal of clinical investigation.

[66]  C. Ward,et al.  Losartan Restores Skeletal Muscle Remodeling and Protects Against Disuse Atrophy in Sarcopenia , 2011, Science Translational Medicine.

[67]  V. Fuster,et al.  Cellular Senescence, Vascular Disease, and Aging: Part 2 of a 2-Part Review Clinical Vascular Disease in the Elderly , 2011, Circulation.

[68]  Takako Sasaki,et al.  Prodomains of transforming growth factor beta (TGFbeta) superfamily members specify different functions: extracellular matrix interactions and growth factor bioavailability. , 2011, The Journal of biological chemistry.

[69]  A. Lucia,et al.  The K153R Polymorphism in the Myostatin Gene and Muscle Power Phenotypes in Young, Non-Athletic Men , 2011, PloS one.

[70]  Yingtang Shi,et al.  Gdf11 Facilitates Temporal Progression of Neurogenesis in the Developing Spinal Cord , 2011, The Journal of Neuroscience.

[71]  Kazuto Nakamura,et al.  Cardiac Myocyte-specific Ablation of Follistatin-like 3 Attenuates Stress-induced Myocardial Hypertrophy* , 2011, The Journal of Biological Chemistry.

[72]  A. Boyle,et al.  The aging heart and post-infarction left ventricular remodeling. , 2011, Journal of the American College of Cardiology.

[73]  L. Patthy,et al.  WFIKKN1 and WFIKKN2 bind growth factors TGFβ1, BMP2 and BMP4 but do not inhibit their signalling activity , 2010, The FEBS journal.

[74]  A. Mcpherron METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11. , 2010, Immunology, endocrine & metabolic agents in medicinal chemistry.

[75]  Tracy R. Keeney,et al.  Aptamer-based multiplexed proteomic technology for biomarker discovery , 2010, PloS one.

[76]  C. Petrilli,et al.  Myostatin activation in patients with advanced heart failure and after mechanical unloading , 2010, European journal of heart failure.

[77]  A. Lucia,et al.  The K153R variant in the myostatin gene and sarcopenia at the end of the human lifespan , 2010, AGE.

[78]  A. Hinck,et al.  Ternary Complex of Transforming Growth Factor-β1 Reveals Isoform-specific Ligand Recognition and Receptor Recruitment in the Superfamily* , 2010, The Journal of Biological Chemistry.

[79]  S. Welle,et al.  Genetic Deletion of Myostatin From the Heart Prevents Skeletal Muscle Atrophy in Heart Failure , 2010, Circulation.

[80]  K. Tsuchida,et al.  Activin A and Follistatin-Like 3 Determine the Susceptibility of Heart to Ischemic Injury , 2009, Circulation.

[81]  C. Murry,et al.  Myostatin represses physiological hypertrophy of the heart and excitation–contraction coupling , 2009, The Journal of physiology.

[82]  M. Mittleman,et al.  Effects of myostatin deletion in aging mice , 2009, Aging cell.

[83]  T. B. Thompson,et al.  The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding , 2009, The EMBO journal.

[84]  S. Hatakeyama,et al.  Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. , 2009, American journal of physiology. Cell physiology.

[85]  T. M. Bradley,et al.  Overexpression of follistatin in trout stimulates increased muscling. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[86]  K. Patel,et al.  Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity , 2009, Proceedings of the National Academy of Sciences.

[87]  Barbara Gayraud-Morel,et al.  Skeletal muscle as a paradigm for regenerative biology and medicine. , 2009, Regenerative medicine.

[88]  Se-Jin Lee,et al.  Redundancy of myostatin and growth/differentiation factor 11 function , 2009, BMC Developmental Biology.

[89]  Xuan Chen,et al.  Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators. , 2008, Molecular endocrinology.

[90]  Chandramohan Kattamuri,et al.  The Structure of FSTL3·Activin A Complex , 2008, Journal of Biological Chemistry.

[91]  N. Rosenthal,et al.  Expression of follistatin-related genes is altered in heart failure. , 2008, Endocrinology.

[92]  L. Patthy,et al.  Both WFIKKN1 and WFIKKN2 Have High Affinity for Growth and Differentiation Factors 8 and 11* , 2008, Journal of Biological Chemistry.

[93]  A. Goldberg,et al.  Identification of a Novel Pool of Extracellular Pro-myostatin in Skeletal Muscle* , 2008, Journal of Biological Chemistry.

[94]  A. Hinck,et al.  Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. , 2008, Molecular cell.

[95]  Barbara Gayraud-Morel,et al.  A role for the myogenic determination gene Myf5 in adult regenerative myogenesis. , 2007, Developmental biology.

[96]  C. Keller,et al.  Increased Wnt Signaling During Aging Alters Muscle Stem Cell Fate and Increases Fibrosis , 2007, Science.

[97]  D. Freyssenet,et al.  Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression. , 2007, Endocrinology.

[98]  C. Bustamante,et al.  A Mutation in the Myostatin Gene Increases Muscle Mass and Enhances Racing Performance in Heterozygote Dogs , 2007, PLoS genetics.

[99]  T. Abraham,et al.  Myostatin does not regulate cardiac hypertrophy or fibrosis , 2007, Neuromuscular Disorders.

[100]  Susan C. Brown,et al.  Lack of myostatin results in excessive muscle growth but impaired force generation , 2007, Proceedings of the National Academy of Sciences.

[101]  E. Rosen,et al.  FSTL3 deletion reveals roles for TGF-β family ligands in glucose and fat homeostasis in adults , 2007, Proceedings of the National Academy of Sciences.

[102]  Zhenguo Wu,et al.  Myostatin Induces Cyclin D1 Degradation to Cause Cell Cycle Arrest through a Phosphatidylinositol 3-Kinase/AKT/GSK-3β Pathway and Is Antagonized by Insulin-like Growth Factor 1* , 2006, Journal of Biological Chemistry.

[103]  L. Klaman,et al.  Administration of myostatin does not alter fat mass in adult mice , 2006, Diabetes, obesity & metabolism.

[104]  L. Mucke,et al.  Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology. , 2006, The Journal of clinical investigation.

[105]  P. Serup,et al.  Analysis of pancreatic endocrine development in GDF11‐deficient mice , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[106]  Jeh-Ping Liu The function of growth/differentiation factor 11 (Gdf11) in rostrocaudal patterning of the developing spinal cord , 2006, Development.

[107]  A. Mukherjee,et al.  Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. , 2006, Endocrinology.

[108]  P. Lepage,et al.  Identification of CD109 as part of the TGF‐β receptor system in human keratinocytes , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[109]  S. Choe,et al.  Structure of the ternary signaling complex of a TGF-β superfamily member , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[110]  C. Ibáñez,et al.  Synergistic interaction between Gdf1 and Nodal during anterior axis development. , 2006, Developmental biology.

[111]  Raymond T Chung,et al.  Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression , 2006, Nature Genetics.

[112]  T. Nishimura,et al.  Decorin binds myostatin and modulates its activity to muscle cells. , 2006, Biochemical and biophysical research communications.

[113]  Yan Chen,et al.  Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression. , 2006, Cancer research.

[114]  Robert W Cook,et al.  The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding. , 2005, Developmental cell.

[115]  C. Woolf,et al.  Repulsive Guidance Molecule (RGMa), a DRAGON Homologue, Is a Bone Morphogenetic Protein Co-receptor* , 2005, Journal of Biological Chemistry.

[116]  D. Greenspan,et al.  GDF11 Forms a Bone Morphogenetic Protein 1-Activated Latent Complex That Can Modulate Nerve Growth Factor-Induced Differentiation of PC12 Cells , 2005, Molecular and Cellular Biology.

[117]  B. Langley,et al.  Proteolytic processing of myostatin is auto-regulated during myogenesis. , 2005, Developmental biology.

[118]  M. Matzuk,et al.  GDF11 Controls the Timing of Progenitor Cell Competence in Developing Retina , 2005, Science.

[119]  A. Brivanlou,et al.  DRAGON, a Bone Morphogenetic Protein Co-receptor* , 2005, Journal of Biological Chemistry.

[120]  Zhijian Lu,et al.  Regulation of GDF-8 signaling by the p38 MAPK. , 2005, Cellular signalling.

[121]  I. Weissman,et al.  Rejuvenation of aged progenitor cells by exposure to a young systemic environment , 2005, Nature.

[122]  L. Whittemore,et al.  Loss of myostatin expression alters fiber‐type distribution and expression of myosin heavy chain isoforms in slow‐ and fast‐type skeletal muscle , 2005, Muscle & nerve.

[123]  Xueying Gu,et al.  GDF11 modulates NGN3+ islet progenitor cell number and promotes β-cell differentiation in pancreas development , 2004, Development.

[124]  D. Rifkin,et al.  Integrin αVβ6-mediated activation of latent TGF-β requires the latent TGF-β binding protein-1 , 2004, The Journal of cell biology.

[125]  K. Patel,et al.  Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. , 2004, Developmental biology.

[126]  W. Sebald,et al.  Molecular recognition of BMP-2 and BMP receptor IA , 2004, Nature Structural &Molecular Biology.

[127]  L. Liang,et al.  Characterization and identification of the inhibitory domain of GDF-8 propeptide. , 2004, Biochemical and biophysical research communications.

[128]  E. Masliah,et al.  Loss of TGF-β1 Leads to Increased Neuronal Cell Death and Microgliosis in Mouse Brain , 2003, Neuron.

[129]  W. N. Pappano,et al.  Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[130]  J. Wrana,et al.  Myostatin Signals through a Transforming Growth Factor β-Like Signaling Pathway To Block Adipogenesis , 2003, Molecular and Cellular Biology.

[131]  Seumas McCroskery,et al.  Myostatin negatively regulates satellite cell activation and self-renewal , 2003, The Journal of cell biology.

[132]  M. Rudnicki,et al.  Wnt Signaling Induces the Myogenic Specification of Resident CD45+ Adult Stem Cells during Muscle Regeneration , 2003, Cell.

[133]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[134]  R. Hewick,et al.  Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains. , 2003, Molecular endocrinology.

[135]  Se-Jin Lee,et al.  Regulation of metanephric kidney development by growth/differentiation factor 11. , 2003, Developmental biology.

[136]  T. Jardetzky,et al.  Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF‐β ligand:receptor interactions , 2003, The EMBO journal.

[137]  Anne L. Calof,et al.  Autoregulation of Neurogenesis by GDF11 , 2003, Neuron.

[138]  R. Hewick,et al.  The Myostatin Propeptide and the Follistatin-related Gene Are Inhibitory Binding Proteins of Myostatin in Normal Serum* , 2002, The Journal of Biological Chemistry.

[139]  L. Ferrucci,et al.  Myostatin Polymorphisms and Age‐Related Sarcopenia in the Italian Population , 2002, Journal of the American Geriatrics Society.

[140]  T. Zimmers,et al.  Induction of Cachexia in Mice by Systemically Administered Myostatin , 2002, Science.

[141]  A. Ebert,et al.  Cripto-1 Activates Nodal- and ALK4-Dependent and -Independent Signaling Pathways in Mammary Epithelial Cells , 2002, Molecular and Cellular Biology.

[142]  M. Azain,et al.  Myostatin knockout in mice increases myogenesis and decreases adipogenesis. , 2002, Biochemical and biophysical research communications.

[143]  Se-Jin Lee,et al.  Suppression of body fat accumulation in myostatin-deficient mice. , 2002, The Journal of clinical investigation.

[144]  T. Jessell,et al.  Assigning the Positional Identity of Spinal Motor Neurons Rostrocaudal Patterning of Hox-c Expression by FGFs, Gdf11, and Retinoids , 2001, Neuron.

[145]  L. Fried,et al.  Polymorphic Variation in the Human Myostatin (GDF‐8) Gene and Association with Strength Measures in the Women's Health and Aging Study II Cohort , 2001, Journal of the American Geriatrics Society.

[146]  Se-Jin Lee,et al.  Regulation of myostatin activity and muscle growth , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[147]  L. Patthy,et al.  A human protein containing multiple types of protease-inhibitory modules , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[148]  V. Rosen,et al.  Gdf11 is a negative regulator of chondrogenesis and myogenesis in the developing chick limb. , 2001, Developmental biology.

[149]  Quazi Shakey,et al.  Gdf-8 Propeptide Binds to GDF-8 and Antagonizes Biological Activity by Inhibiting GDF-8 Receptor Binding , 2001, Growth factors.

[150]  R. Ferrell,et al.  Frequent sequence variation in the human myostatin (GDF8) gene as a marker for analysis of muscle-related phenotypes. , 1999, Genomics.

[151]  K. Matthews,et al.  Myostatin, a transforming growth factor‐β superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct , 1999, Journal of cellular physiology.

[152]  Se-Jin Lee,et al.  Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11 , 1999, Nature Genetics.

[153]  V. Rosen,et al.  A novel BMP expressed in developing mouse limb, spinal cord, and tail bud is a potent mesoderm inducer in Xenopus embryos. , 1999, Developmental biology.

[154]  A. Joyner,et al.  Expression of growth/differentiation factor 11, a new member of the BMP/TGFβ superfamily during mouse embryogenesis , 1999, Mechanisms of Development.

[155]  Se-Jin Lee,et al.  Double muscling in cattle due to mutations in the myostatin gene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[156]  Se-Jin Lee,et al.  Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member , 1997, nature.

[157]  R. Beavis,et al.  Identification and Characterization of an Eight-cysteine Repeat of the Latent Transforming Growth Factor-β Binding Protein-1 that Mediates Bonding to the Latent Transforming Growth Factor-β1* , 1996, The Journal of Biological Chemistry.

[158]  J. Taipale,et al.  Association of the small latent transforming growth factor‐beta with an eight cysteine repeat of its binding protein LTBP‐1. , 1996, The EMBO journal.

[159]  A. Maseri,et al.  Age-Related Increase in Mortality among Patients with First Myocardial Infarctions Treated with Thrombolysis , 1993 .

[160]  J. Massagué,et al.  Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. , 1992, The Journal of biological chemistry.

[161]  K. Miyazono,et al.  A role of the latent TGF‐beta 1‐binding protein in the assembly and secretion of TGF‐beta 1. , 1991, The EMBO journal.

[162]  A. Mason,et al.  Requirement for activin A and transforming growth factor--beta 1 pro-regions in homodimer assembly. , 1990, Science.

[163]  K. Motonishi,et al.  Quantitative estimations of five classes of immunoglobulin in inbred mouse strains. , 1977, Immunology.

[164]  Ji-Hyun Lee,et al.  Effective RNA-silencing strategy of Lv-MSTN/GDF11 gene and its effects on the growth in shrimp, Litopenaeus vannamei. , 2015, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[165]  K. Walsh,et al.  Cardiometabolic effects of adiponectin. , 2014, Best practice & research. Clinical endocrinology & metabolism.

[166]  H. Keutmann,et al.  Heparin and activin-binding determinants in follistatin and FSTL3. , 2005, Endocrinology.